Epidermal aspects of type VII collagen: Implications for dystrophic epidermolysis bullosa and epidermolysis bullosa acquisita

被引:19
|
作者
Watanabe, Mika [1 ]
Natsuga, Ken [1 ]
Shinkuma, Satoru [2 ]
Shimizu, Hiroshi [1 ]
机构
[1] Hokkaido Univ, Dept Dermatol, Grad Sch Med, North 15 West 7, Sapporo, Hokkaido 0608638, Japan
[2] Niigata Univ, Div Dermatol, Grad Sch Med & Dent Sci, Niigata, Japan
来源
JOURNAL OF DERMATOLOGY | 2018年 / 45卷 / 05期
关键词
COL7A1; epidermolysis bullosa; keratinocytes; squamous cell carcinoma; type VII collagen; SQUAMOUS-CELL CARCINOMA; BONE-MARROW-TRANSPLANTATION; PLURIPOTENT STEM-CELLS; BASEMENT-MEMBRANE; REVERTANT MOSAICISM; GENE-EXPRESSION; STRUCTURAL ORGANIZATION; PROCOLLAGEN-VII; JUNCTION ZONE; MESSENGER-RNA;
D O I
10.1111/1346-8138.14222
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Type VII collagen (COL7), a major component of anchoring fibrils in the epidermal basement membrane zone, has been characterized as a defective protein in dystrophic epidermolysis bullosa and as an autoantigen in epidermolysis bullosa acquisita. Although COL7 is produced and secreted by both epidermal keratinocytes and dermal fibroblasts, the role of COL7 with regard to the epidermis is rarely discussed. This review focuses on COL7 physiology and pathology as it pertains to epidermal keratinocytes. We summarize the current knowledge of COL7 production and trafficking, its involvement in keratinocyte dynamics, and epidermal carcinogenesis in COL7 deficiency and propose possible solutions to unsolved issues in this field.
引用
收藏
页码:515 / 521
页数:7
相关论文
共 50 条
  • [31] Epidermolysis bullosa acquisita
    Kim, J. H.
    Kim, S. -C.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2013, 27 (10) : 1204 - 1213
  • [32] Epidermolysis bullosa acquisita
    Caux, Frederic
    PRESSE MEDICALE, 2010, 39 (10): : 1081 - 1088
  • [33] Detection of anti-type VII collagen IgE antibodies in epidermolysis bullosa acquisita
    Koga, H.
    Teye, K.
    Yamashita, K.
    Ishii, N.
    Ohata, C.
    Nakama, T.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (05) : S45 - S45
  • [34] Detection of anti-type VII collagen IgE antibodies in epidermolysis bullosa acquisita
    Koga, H.
    Teye, K.
    Yamashita, K.
    Ishii, N.
    Tsuruta, D.
    Nakama, T.
    BRITISH JOURNAL OF DERMATOLOGY, 2019, 180 (05) : 1107 - 1113
  • [35] The cartilage matrix protein subdomain of type VII collagen is pathogenic for epidermolysis bullosa acquisita
    Chen, Mei
    Doostan, Arvin
    Bandyopadhyay, Pubali
    Remington, Jennifer
    Wang, Xinyi
    Hou, Yingping
    Liu, Ziu
    Woodley, David T.
    AMERICAN JOURNAL OF PATHOLOGY, 2007, 170 (06): : 2009 - 2018
  • [36] PATHOMORPHOGENESIS OF BLISTERING IN EPIDERMOLYSIS BULLOSA ACQUISITA AND EPIDERMOLYSIS BULLOSA DYSTROPHICA
    METZ, J
    FRANK, H
    METZ, G
    ARCHIV FUR DERMATOLOGISCHE FORSCHUNG, 1975, 254 (01): : 103 - 112
  • [37] Dystrophic epidermolysis bullosa modulated in the setting of compound heterozygous type VII collagen mutations
    Harlan, Eric
    Reese, Erin
    Sluzevich, Jason
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 62 (03) : AB73 - AB73
  • [38] Gentamicin induces functional type VII collagen in recessive dystrophic epidermolysis bullosa patients
    Woodley, David T.
    Cogan, Jon
    Hou, Yingping
    Lyu, Chao
    Marinkovich, M. Peter
    Keene, Douglas
    Chen, Mei
    JOURNAL OF CLINICAL INVESTIGATION, 2017, 127 (08): : 3028 - 3038
  • [39] Injection of recombinant human type VII collagen restores collagen function in dystrophic epidermolysis bullosa
    Woodley, DT
    Keene, DR
    Atha, T
    Huang, Y
    Lipman, K
    Li, W
    Chen, M
    NATURE MEDICINE, 2004, 10 (07) : 693 - 695
  • [40] THE EPIDERMOLYSIS BULLOSA-ACQUISITA ANTIGEN IS TYPE-VII PROCOLLAGEN
    WOODLEY, DT
    BURGESON, RE
    LUNSTRUM, GP
    REESE, MJ
    BRUCKNERTUDERMAN, L
    GAMMON, WR
    BRIGGAMAN, RA
    CLINICAL RESEARCH, 1987, 35 (03): : A726 - A726